Bortezomib and gemcitabine in relapsed or refractory Hodgkins lymphoma.
J. H. Mendler; J. Kelly; S. Voci; D. Marquis; L. Rich; R. M. Rossi; S. H. Bernstein; C. T. Jordan; J. Liesveld; R. I. Fisher; J. W. Friedberg; Annals of Oncology, 2008, vol. 19, issue 10, p 1759, ISSN 09237534. ISBN 15698041.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef